Difference between revisions of "Negative for intraepithelial lesion or malignancy"
Jump to navigation
Jump to search
(more) |
|||
Line 8: | Line 8: | ||
==See also== | ==See also== | ||
*[[Gynecologic cytopathology]]. | *[[Gynecologic cytopathology]]. | ||
*[[Uterine cervix]]. | |||
==References== | ==References== |
Revision as of 15:34, 26 December 2013
Negative for intraepithelial lesion or malignancy, abbreviated NILM,[1] is the common terminology for - both of the following:
- No SIL is present.
- No malignancy is present.
NILM does not exclude the presence of other findings, e.g. candida.[2]
See also
References
- ↑ Sturgis, CD.; Schaaf, MR.; Tickman, RJ. (May 2013). "Focused rescreening of NILM Pap slides from women ≥ 30 years of age with positive high risk HPV DNA: an enhanced quality control measure.". Diagn Cytopathol 41 (5): 399-403. doi:10.1002/dc.22829. PMID 22351303.
- ↑ Moriarty, AT.; Darragh, TM.; Fatheree, LA.; Souers, R.; Wilbur, DC. (Aug 2009). "Performance of Candida--fungal-induced atypia and proficiency testing: observations from the College of American Pathologists proficiency testing program.". Arch Pathol Lab Med 133 (8): 1272-5. doi:10.1043/1543-2165-133.8.1272. PMID 19653724.